Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - imiquimod, quantity: 12.5 mg - cream - excipient ingredients: benzyl alcohol; purified water; methyl hydroxybenzoate; isostearic acid; xanthan gum; glycerol; white soft paraffin; polysorbate 60; stearyl alcohol; propyl hydroxybenzoate; sorbitan monostearate; cetyl alcohol - ? treatment of solar (actinic) keratosis on the face and scalp (see precautions), and ,? primary treatment of confirmed superficial basal cell carcinoma where surgery is considered inappropriate, and ,? treatment of external genital and perianal warts/condyloma acuminata in adults (see precautions).

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - naphthalophos - oral solution/suspension - naphthalophos organophosphorus active 800.0 g/kg - parasiticides - lamb | sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - barber's pole worm-haemonchus contortus | black scour worm - trichostrongylus spp. | small brown stomach worm-ostertagia spp. | stomach hair worm | thin necked intestinal worm | hair worm | intestinal hair worm | small hair worm | teladorsagia

European Union - English - EMA (European Medicines Agency)

viatris healthcare limited - imiquimod - condylomata acuminata; keratosis; keratosis, actinic; carcinoma, basal cell - antibiotics and chemotherapeutics for dermatological use - imiquimod cream is indicated for the topical treatment of :external genital and perianal warts (condylomata acuminata) in adults.small superficial basal cell carcinomas (sbccs) in adults.clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses (aks) on the face or scalp in immunocompetent adult patients when size or number of lesions limit the efficacy and/or acceptability of cryotherapy and other topical treatment options are contraindicated or less appropriate.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - imiquimod -

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - imiquimod, quantity: 50 mg/g - cream - excipient ingredients: benzyl alcohol; glycerol; white soft paraffin; stearyl alcohol; isostearic acid; sorbitan monostearate; propyl hydroxybenzoate; xanthan gum; polysorbate 60; purified water; methyl hydroxybenzoate; cetyl alcohol - aldara 5% cream is indicated for treatment of solar (actinic) keratosis on the face and the scalp (see precautions), and primary treatment of confirmed superficial basal cell carcinoma where surgery is considered inappropriate, and the treatment of external genital and peri-anal warts (condyloma acuminata) in adults (see precautions).

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

meda pharmaceuticals ltd - imiquimod - cream - 50mg/1gram

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - imiquimod, quantity: 50 mg/g - cream - excipient ingredients: methyl hydroxybenzoate; cetyl alcohol; xanthan gum; propyl hydroxybenzoate; polysorbate 60; isostearic acid; glycerol; white soft paraffin; benzyl alcohol; stearyl alcohol; purified water; sorbitan monostearate - aldara 5% cream is indicated for treatment of solar (actinic) keratosis on the face and the scalp (see precautions), and primary treatment of confirmed superficial basal cell carcinoma where surgery is considered inappropriate, and the treatment of external genital and peri-anal warts (condyloma acuminata) in adults (see precautions).

United States - English - NLM (National Library of Medicine)

amneal pharmaceuticals llc - norelgestromin (unii: r0tay3x631) (norelgestromin - unii:r0tay3x631), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - zafemy® is indicated for the prevention of pregnancy in women with a body mass index (bmi) < 30 kg/m2 for whom a combined hormonal contraceptive is appropriate. limitations of use: zafemy may be less effective in preventing pregnancy in women who weigh 198 lbs (90 kg) or more. zafemy is contraindicated for use in women with bmi ≥ 30 kg/m2  [see contraindications (4), warnings and precautions (5.1) and clinical studies (14)]. zafemy is contraindicated in females who are known to have or develop the following conditions: - at high risk of arterial or venous thromboembolic events. examples include women who: - smoke, if over age 35 [see boxed warning, and warnings and precautions (5.1)] - have deep vein thrombosis or pulmonary embolism, now or in the past [see warnings and precautions (5.1)] - have inherited or acquired hypercoagulopathies [see warnings and precautions (5.1)] - have cerebrovascular disease [see warnings and precautions (5.1)] - have coronary artery disease [see warnings and precautions (5.1)]

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

inova pharmaceuticals (singapore) pte ltd (incorporated in singapore) malaysia branch - imiquimod -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - abamectin; naphthalophos - oral solution/suspension - abamectin anthelmintic active 2.0 g/l; naphthalophos organophosphorus active 800.0 g/kg - parasiticides - sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - internal parasite | nasal bot | sheep itch mite | haemonchus spp. | ostertagia spp. | psorobia ovis | sheep nasal bot fly | stomach flukes | tapeworm